Latest / Psychopharmacology Today / Ep. 14: Why Every Psychologist Needs Psychopharmacology Training
Transcript
- 0:05Dr. George Kapalka is a prescribing and clinical psychologist based in Albuquerque,
- 0:10New Mexico. He is board certified in clinical psychology and is a fellow
- 0:14of the American Psychological Association's Divisions 53 and 55.
- 0:18He has been a prescribing psychologist for nearly a decade
- 0:21and a practicing psychologist for over 35 years.
- 0:24His work primarily focuses on the psychological,
- 0:28pharmacological, and combined treatments of youth,
- 0:32as well as collaboration between medical and mental health professionals.
- 0:36He has developed and led graduate training programs and currently
- 0:39is the program director of the MS in Clinical Psychopharmacology
- 0:43at Alliant University, where he holds the rank of Distinguished Professor.
- 0:47He is an author of six books and dozens of other publications
- 0:52and professional presentations.
- 0:53He has been interviewed in newspapers,
- 0:56internet publications, and on television.
- 0:58He hosts the blog "Kids and Psych Meds" on Psychology Today.
- 1:03So welcome, Dr. Kapalka. I'll turn it over to you.
- 1:06Thank you. Welcome, everyone! We will talk today about something that's been
- 1:11a major part of my life, which is
- 1:13practice in the area of not just clinical psychology,
- 1:17but specifically psychopharmacology.
- 1:19So we're going to talk today a little bit about the need,
- 1:24why psychologists should complete training
- 1:28in psychopharmacology for various types of activities they may perform,
- 1:33not just limited to prescribing,
- 1:36but of course,
- 1:37psychologists who don't prescribe medications also benefit greatly from completing
- 1:41this training. ~ We'll talk about ~ how our patients benefit,
- 1:46we'll talk about how our practices can be enhanced by doing that.
- 1:50We'll talk a little bit about the history of psychopharmacology training
- 1:56for psychologists and how that came about,
- 1:59because it really is quite fascinating and has only been around for about
- 2:0430 years, which in the life of psychology as a profession is a relatively
- 2:09~ brief period. And then we'll review the models of training ~
- 2:14as they are exemplified by the current MSCP programs that are out there,
- 2:21including Alliant's. And the goal of that is to help everyone think
- 2:28about one, how
- 2:31obtaining training in psychopharmacology can be helpful to you as
- 2:34a psychologist or a graduate student on the way to becoming a psychologist,
- 2:38but also too, if you are thinking about this kind of training,
- 2:41to kind of understand the difference between the different programs
- 2:45and then see what kind of training model may actually work well for you.
- 2:51So let's start with outlining the need
- 2:55for psychological
- 2:56services period, but especially for ~ services that have
- 3:00to do with psychopharmacology.
- 3:02In the US, the lifetime prevalence for a significant mental health condition,
- 3:07that may be diagnosable in accordance with what's in the DSM system,
- 3:11is nearly half of Americans experience something like that
- 3:18in their lifetime. That's a very significant number.
- 3:20And you can see when you look at the age breakdowns that in some age groups,
- 3:26for example, 18 to 25, that's actually more than a third.
- 3:31So that's a very significant number of people.
- 3:36And the more than a third is annual prevalence,
- 3:40right? The statistic on top is lifetime prevalence.
- 3:43Of course,
- 3:44lifetime prevalence will be a different statistic than annual prevalence.
- 3:49But looking at annual prevalence of more than a third,
- 3:53I think that's a very significant number of Americans that need mental health care.
- 3:58It so happens that our lives are such that
- 4:02we regularly experience traumatic events of a variety of sorts in our life.
- 4:09You know, nearly three-quarters of Americans experience at least
- 4:13one traumatic event. And about two-thirds of Americans experience
- 4:19at least one adverse childhood event before age 18.
- 4:23So a significant portion of our population gets traumatized early,
- 4:29right? So the effects of early traumatization,
- 4:32of course, can last and can affect a person's life in some very significant ways.
- 4:37And we can see that ~ among our youth the ~ experience of two or more
- 4:43or even four or more of these traumatizing events is actually not that rare.
- 4:49It's more than a sixth. So again,
- 4:51that's a significant portion of our population.
- 4:54These traumatic events may include abuse,
- 4:58neglect, household challenges.
- 5:00The number of these events correlate with the degree to which people then have
- 5:06future mental health problems,
- 5:07and some of them end up in foster placement,
- 5:10which of course is another traumatizing event,
- 5:14you know, on top of everything else that has happened.
- 5:17About 20% of adults receive any ~ mental health treatment
- 5:23in any given year. That's data according to the National Center
- 5:28for Health Statistics. It's really interesting to see that ~ you know,
- 5:33about a sixth, maybe a little bit more,
- 5:35receive treatment with medications,
- 5:38while only about ten percent
- 5:40receive treatment with psychotherapy.
- 5:42So ~ one of the points that I will focus on during this presentation today
- 5:46is that medication treatment is more common than psychotherapy treatment.
- 5:50So that again kind of plants the seed here of why it is
- 5:55so important for psychologists to complete training in psychopharmacology.
- 6:00And one reason is that such a large proportion of our population is actually treated
- 6:07~ with medications. Interestingly also,
- 6:10~ the National Center for Health Statistics has reported that reviewing
- 6:1720 years of data, they've noticed that the percent of medication
- 6:21use is on the increase and the percent of psychotherapy use is actually
- 6:26on the decrease. And we'll talk about some reasons why that is the case.
- 6:31About half of those with mental health problems do not receive treatment.
- 6:35That's really a concerning statistic,
- 6:39and it shows that there is such an unmet need for mental health care in the US.
- 6:45And alarmingly, more than two-thirds of adolescents with mental health problems
- 6:51do not receive treatment.
- 6:53That is particularly important to me since my practice primarily is with kids
- 6:58and adolescents. So I am very concerned about the lack of access
- 7:02to treatment for our young people in the country.
- 7:05It can be very difficult finding a mental health provider,
- 7:08and you can see that in comparison with either primary care or other types
- 7:13of medical specialists,
- 7:15it's actually a lot more difficult for people to find a mental health therapist
- 7:19or a mental health prescriber,
- 7:21at least twice more difficult than any other specialty,
- 7:25if not even more than that. And there are very significant psychiatric shortages
- 7:30in the US. There are about 11.5 psychiatrists for every 100,000 people
- 7:35in the country. And for pediatric psychiatrists,
- 7:39those rates are really alarmingly low,
- 7:43at about four per 100,000.
- 7:46To give you a sense of reference,
- 7:49somewhere between 20, 25 to 30 per 100,000 would
- 7:55be considered approximately what ~ would meet the need for the population.
- 8:02So we're seeing these numbers are much lower than what we really need
- 8:08to adequately treat ~ mental health issues
- 8:11in our population.
- 8:1360% of US counties don't have a psychiatric prescriber,
- 8:17and as many as 80% of rural counties in the US don't have a psychiatric prescriber.
- 8:23More than 90% of US counties have no pediatric psychiatric prescriber.
- 8:30And again, these are very alarming statistics.
- 8:33And there are some consequences of that,
- 8:36and we'll briefly talk about what that is.
- 8:41Reasons for that are multiple.
- 8:43You know, there's a lot of shortage in terms of how many people actually
- 8:48go into the profession of psychiatry.
- 8:51And insurance coverage also in many cases makes it more difficult
- 8:58to seek mental health treatment as compared to other medical specialties.
- 9:03So that definitely is another factor
- 9:05that contributes to why there are treatment shortages in mental health care
- 9:11in the US. The cost is often an obstacle.
- 9:15A far greater proportion
- 9:19of mental health providers tend to be out of network than
- 9:24for other medical specialties,
- 9:26of which there's much higher percentages of those specialists being in
- 9:31most insurance networks. So, you know,
- 9:34as many as 80% of patients with employer health plans have to go out
- 9:38of network for mental health care.
- 9:40That means greater costs. Because typically when you go out of network,
- 9:45first of all, some insurance plants don't have out-of-network benefits,
- 9:49period. And those that do, generally the cost out of pocket from
- 9:54the patients is higher than if you go in network.
- 9:59A lot of psychiatrists don't take insurance,
- 10:01a lot of psychiatrists don't accept new patients.
- 10:05So median wait for psychiatric care is two months or more.
- 10:10Many people consider this number of 67 days to actually be on the low side,
- 10:16because in significant portions of the country,
- 10:19that number is actually a lot higher.
- 10:22One of the results of that is that the majority of psychotropics
- 10:25are prescribed in primary care.
- 10:27Depending on what study you look at,
- 10:30it's anywhere between about 60 to over 70,
- 10:34maybe as many as 75% of psychotropics tend to be prescribed
- 10:39in primary care rather than by specialists.
- 10:42For pediatrics, that's even higher because depending on what study you look at,
- 10:48anywhere between 60 and 85%
- 10:50of all psychotropic medications prescribed to kids or adolescents
- 10:54are prescribed by pediatricians,
- 10:56right? And another really interesting statistic is that for pediatric patients
- 11:02who receive mental health treatment,
- 11:04only about 15% of them receive psychotherapy only as a treatment.
- 11:09So what we're seeing here is that the majority of this mental health treatment
- 11:14is by prescribing medications.
- 11:16Among psychiatrists, you can see that they tend to prescribe a lot of medications.
- 11:21About 60% of visits involve a prescription for at least two medications,
- 11:26and one-third of all psychiatric visits,
- 11:29according to insurance data, involves a prescription for three
- 11:34or more psychotropics. So one of the themes that is emerging here
- 11:39is that psychiatric treatment,
- 11:41when done by psychiatrists, typically involves the use of multiple medications.
- 11:47Medication-only is the most common mental health treatment for pediatric patients.
- 11:51And you can look at this data here from the Truven Health Survey.
- 11:57It was a very large survey involving about one million insurance claims.
- 12:02And you can see that more than half received medication-only as a treatment.
- 12:09About a quarter involved
- 12:12at least some provision of psychotherapy with medications,
- 12:15and only about a sixth were treated with psychotherapy only.
- 12:20One of the additional factors here that we need to consider
- 12:24is that since such a large percentage of mental health care
- 12:30is delegated to primary care because it is so difficult for people
- 12:33to find specialists, that results in...
- 12:38you know, lack of follow-through on patients' parts to be able
- 12:42to obtain mental health care when they're being referred.
- 12:46So essentially, we have a situation like a general ~ health practitioner,
- 12:53a PCP, is seeing a patient who is reporting some symptoms of depression.
- 12:57Data shows that if that person,
- 13:01if that PCP refers
- 13:03the patient for outside treatment,
- 13:06either with a psychiatrist or with a psychologist,
- 13:09only about one-sixth of them will be successful in obtaining that outside mental
- 13:15health treatment. And that speaks to why such a large portion
- 13:20of mental health prescriptions are written in primary care.
- 13:25It's because these primary care practitioners know that if they don't do that,
- 13:31essentially what it means is that the patient will not receive any treatment.
- 13:35"I went from channel to channel seeking relief,
- 13:37but none of the commercials helped me." So that's an additional factor,
- 13:43right? That there are these additional influences that further make
- 13:49it more likely that treatment with medications will be the most commonly utilized
- 13:54treatment in the US.
- 13:56Managed healthcare prefers medication treatment,
- 13:59especially for people who are covered in public health plans like Medicaid.
- 14:04For mental health care, especially for psychotherapy,
- 14:08there may be limited reimbursement rates and pretty difficult,
- 14:14pretty time-consuming pre-authorization requirements
- 14:18to continue receiving treatment.
- 14:21These shortages are especially evident in pediatric psychological care.
- 14:26Because of the difficulty in finding providers,
- 14:29difficulty in being able to follow through on referrals,
- 14:34difficulty in being able to afford,
- 14:36in some cases, you know, specialized mental health care like that by a psychologist,
- 14:42a lot of patients and even a lot of primary care providers don't appreciate just
- 14:48how effective some psychotherapy interventions can be,
- 14:52and that in fact sometimes they can be preferred
- 14:55to utilizing prescription medications.
- 14:58So, this is again, I'm kind of planting the seed here that if
- 15:02we as psychologists obtain training in psychopharmacology,
- 15:09now we become better able to communicate with these primary care practitioners,
- 15:14especially, and in the case of kids and adolescents with pediatricians,
- 15:19so that we can be part of that conversation in terms of what treatments
- 15:25are best for their patients. And sometimes that may be medication,
- 15:30but sometimes that may be psychotherapy.
- 15:33If we're at the proverbial table when these conversations are taking place,
- 15:38we can have more influence into those decisions.
- 15:42So what are the opportunities for us if we obtain training in psychopharmacology?
- 15:48So first of all, awareness of treatments with psychotropic medications
- 15:54is a skill set that really now is expected of all psychologists,
- 16:00right?
- 16:01And 25 states explicitly allow psychologists to discuss medication treatment with
- 16:06their patients, and no state currently prohibits it.
- 16:10~ Generally, the provision is that psychologists should engage
- 16:17in these conversations to the extent to which their training
- 16:22and background prepares them to be able to do so.
- 16:25So once again, a psychologist who completes training in psychopharmacology
- 16:30is far more able to have these discussions with the prescribing physician
- 16:36and make meaningful contributions to the decisions about what medications
- 16:41are utilized and whether or not medication is a better option,
- 16:45or maybe another treatment would be better.
- 16:48So here's an example of the statement that's actually in the California law.
- 16:53Depending on which state you practice,
- 16:55you may want to look into your own ~ licensing statutes and rules
- 17:01to see whether or not your state has something that specifically
- 17:07speaks to that. And again, the language usually is something to the effect
- 17:13of these conversations are permitted and even encouraged
- 17:18to the extent to which the psychologists have the sufficient background
- 17:23to engage in these types of communications.
- 17:25A really exciting development because of how recently it
- 17:31has been revised is the American Psychological Association Guidelines
- 17:36for Psychologists' Involvement in Psychopharmacological Issues.
- 17:40We're very excited
- 17:42that two of our faculty members from our MSCP program at Alliant were actually part
- 17:48of the revisions of these guidelines.
- 17:51And these guidelines were pretty comprehensively revised.
- 17:56So I'd like to review some aspects of these guidelines because
- 18:02what these guidelines do is they exemplify why it is so beneficial
- 18:09for our patients
- 18:10when psychologists become involved
- 18:14in these psychopharmacological issues,
- 18:18in making decisions about medications and also in monitoring how patients
- 18:23are doing in medications.
- 18:26The point that I will make and then kind of go through it
- 18:32in various sections here is that we tend to look at
- 18:37all aspects of treatment in more depth and from a greater variety
- 18:44of angles than it tends to be looked at by other professionals,
- 18:50by psychiatrists, because frankly often they choose not to,
- 18:55by primary care professionals,
- 18:58because to be honest, most
- 19:01primary care sessions last 15 to 20 minutes.
- 19:05You have so much to do because you're providing general medical care during that
- 19:1115 to 20 minutes that your ability to spend so much time reviewing what
- 19:18I'm about to go through here is limited.
- 19:21So, realistically speaking, primary care practitioners just don't have the luxury
- 19:26to be able to go into some of these things in as much depth as we can,
- 19:30right? So this is why, once again,
- 19:33a psychologist's involvement in psychopharmacological issues becomes
- 19:37so beneficial to the patient, because we can,
- 19:40at much greater depth, have these conversations and help patients decide what really
- 19:47is best for them regarding treatment.
- 19:50So these ~ guidelines have some general provisions that first of all warn
- 19:55us about awareness of limitations of our competence and that we should have these
- 19:59conversations to the extent to which we have background and training
- 20:03in this area preparing us to be able to do so.
- 20:06We should evaluate our beliefs and attitudes about the role of medications.
- 20:11So here we need to be careful not to be biased either for medications
- 20:16or against medications.
- 20:18But to try to maintain a neutral stance that is primarily driven
- 20:23by what is best for the patient and also what the data shows in terms
- 20:28of which treatments have been shown to be beneficial.
- 20:32Sensitivity to developmental, age,
- 20:35educational, and other issues.
- 20:37Think about how ~ much that permeates our treatment as psychologists,
- 20:43period.
- 20:44So when we become involved in psychopharmacological conversations,
- 20:47we continue to bring that sensitivity.
- 20:50And again, it's so much greater because of who we are than when these conversations
- 20:56are done by other types of professionals.
- 20:59Education has to do with the knowledge and training that we have
- 21:04to maintain currency in this area if we continue to be active in this area.
- 21:10Knowledge of awareness of the effects of medication,
- 21:13and that means both beneficial effects as well as adverse effects,
- 21:18so that we can contribute to the monitoring of these effects of medications.
- 21:23Awareness of technological resources that enhance the decision making.
- 21:28Here specifically, it really pertains rather than to AI,
- 21:33which may have some benefit,
- 21:36but it's still largely unproven in terms of how involved it can
- 21:41be in independent decision making.
- 21:42This is more regarding access to current information so that
- 21:47the psychologist who practices in this area can be aware of
- 21:52the latest developments as it comes to treatment choices and the effects
- 21:56of these medications. Assessment.
- 21:58Think about the depth
- 22:01of assessment that takes place in a psychologist's office as compared
- 22:05to other professions, whether it's primary care or even psychiatry,
- 22:10right? We tend to focus a lot more on the depth,
- 22:16the quality, and the breadth of the assessment.
- 22:19And when it comes to ~ medications,
- 22:21of course, that means monitoring both the psychological and physical effects
- 22:27of the medication and monitoring the physiological status when that
- 22:32can be affected by medications.
- 22:34So for example, let's say we're working with a patient who was taking
- 22:39a medication like Effexor. A pharmacologically trained psychologist understands that
- 22:45Effexor, for some patients, may raise their blood pressure.
- 22:49So we as psychologists tend to see patients once every week,
- 22:54maybe once every other week, certainly more frequently than
- 22:58a primary care practitioner who may be writing that prescription.
- 23:02Then our involvement with this patient may include a routine blood pressure check
- 23:08when they come into our offices,
- 23:10because we understand that that could be a particular risk of that medication.
- 23:16Intervention and consultation,
- 23:18so that we recommend medication in the context of an existing relationship
- 23:23we already have with the patient,
- 23:25and that we employ a shared decision-making model.
- 23:29Now think about the extent to which that shared decision-making model
- 23:34is utilized in other medical professions.
- 23:38I think it is utilized more so now than perhaps it was 20 or 30 years ago,
- 23:43but we still are much more used to having those types
- 23:48of conversations and utilizing this approach than a lot
- 23:52of other medical professionals.
- 23:54One aspect I'd like to point out,
- 23:56because again, it really exemplifies the depth to which we review these matters when
- 24:02we involve the medication issues,
- 24:04is look at the Guidelines' recommendations for what
- 24:10the informed consent that involves medications should include.
- 24:14Now here are some of the aspects.
- 24:17I will not read them all.
- 24:19But you can kind of see how comprehensive this is and
- 24:24how much we're expected to take into consideration when
- 24:29we discuss the potential use of medications with the patient.
- 24:33So again, the point here is we do it in more depth,
- 24:37more comprehensively, and we involve the patient
- 24:41in the decision-making process,
- 24:43so much more than other medical specialties
- 24:48or medical professionals tend to do.
- 24:50And finally, we maintain the appropriate relationship with other providers when
- 24:56we treat a shared patient so that it continues to be
- 25:01a shared decision-making model between the patient,
- 25:04the psychologist, as well as the ~
- 25:07prescribing physician.
- 25:08Now, something that APA actually implemented as
- 25:14a recommendation about 30 years ago,
- 25:16and these Guidelines for Psychologists' Involvement
- 25:20in Psychopharmacological Issues have reiterated in the latest revision, is that
- 25:26there are these three levels of training.
- 25:28So Level I is recommended of all psychologists.
- 25:33And Level II and Level III is a higher level of training,
- 25:37which now would involve the obtainment of the MS in Clinical Psychopharmacology.
- 25:43And that allows you a far greater contribution to medication decision-making
- 25:49for your patients. So Level I training typically is an equivalent
- 25:53of a graduate-level course in psychopharmacology,
- 25:55that a lot, but not all, unfortunately,
- 25:58doctoral programs in psychology may
- 26:00have. If you have not had that kind of a course in your ~ graduate training,
- 26:07~ in your doctoral program, you can certainly obtain equivalent training yourself
- 26:12as part of continuing education classes.
- 26:15Of course you should maintain currency,
- 26:17and this kind of training allows you to sensitize the patient to ~ whether
- 26:23or not they may benefit from medications,
- 26:25to think about whether or not they're experiencing ~
- 26:29you know, side effects, and then to encourage them to have these conversations with
- 26:35their prescribing professionals.
- 26:37It's when we get into the level of training that is the Level II or Level
- 26:41III that we're talking about greater contribution from psychologists.
- 26:45So this is where the training would be obtaining the
- 26:49MS in Clinical Psychopharmacology.
- 26:51The Designation Criteria have a lot of
- 26:55definitions about what that training needs to look like,
- 26:58at least 400 hours. There's areas of training that are explained and mandated
- 27:04in the Designation Criteria. And those include the practical experience
- 27:09in physical health assessment.
- 27:11Level II training has a lot of benefits because that level of training,
- 27:17even if you are not a prescriber,
- 27:18just obtaining Level II training allows you to have this kind
- 27:22of conversation with physicians that I was just talking about.
- 27:24And it greatly enhances your practice too,
- 27:28because now with this additional training,
- 27:31you can approach physicians and let them know that you have a lot
- 27:35of knowledge about psychotropic medications.
- 27:38You can help them with this decision making,
- 27:41selecting the best medication.
- 27:43You can help them monitor
- 27:45how their patients are responding to these medications,
- 27:48right? So we have very substantive contributions that we can make
- 27:53to this shared decision making between all parties involved,
- 27:56which not only benefits our patient,
- 27:58but it also can significantly enhance our practice.
- 28:02Level III training is when you can actually become a prescribing psychologist.
- 28:07Nine states currently
- 28:09allow psychologists to prescribe medications.
- 28:12We've actually had two states pass it in 2026,
- 28:17which is the first time we've had two states pass prescriptive authority.
- 28:21We're very excited about this and I think the momentum has really built
- 28:26and hopefully will continue so that more and more states pass RxP.
- 28:31Studies
- 28:32have shown by several groups of researchers now;
- 28:38Hughes and Colleagues is one group that's been doing this more recently.
- 28:41Maybe about ten years earlier than Hughes,
- 28:45et al. McGrath and Colleague did a lot of research as well,
- 28:49showing the benefits of what happens when states pass prescriptive authority.
- 28:56And the benefits to the populations are very,
- 28:59very significant, including things like drop in suicide rates
- 29:02and definitely greater access to
- 29:06psychological care.
- 29:07So completing psychopharmacology training expands opportunities,
- 29:12especially when you're talking about Level II or III,
- 29:15and that means obtaining the MSCP.
- 29:18And there are many ways in which that can enhance your practice.
- 29:22Primary care practitioners generally welcome collaborative care with
- 29:27pharmacologically trained psychologists.
- 29:30Integrated care, where psychologists are embedded into primary care,
- 29:35that in itself has been expanding across the country.
- 29:40This means increased income opportunities for psychologists.
- 29:44The more psychologists complete MSCP training in any given state,
- 29:49that likely improves the chances of that state passing prescriptive authority
- 29:54because there is now a cadre of professionals who would be ready
- 29:58to start prescribing
- 29:59if the law was passed in that state allowing them to do so.
- 30:03And that's a powerful argument for legislators.
- 30:06And of course, our patients greatly benefit when psychologists know more about
- 30:11medications.
- 30:12So let's go into the training
- 30:15models. So briefly, just to give you some historical outline,
- 30:21the first psychopharmacology training for psychologists that occurred in
- 30:27any kind of an organized way was in the Department of Defense in what they called
- 30:32the Psychopharmacology for Psychologists Demonstration Project,
- 30:36which ~ started to be talked about in the late 1980s.
- 30:40The first cohort enrolled in 1991,
- 30:45and four cohorts graduated.
- 30:48The program unfortunately was phased out in 1997,
- 30:55ostensibly because it was too expensive;
- 30:58most people recognize that it was because of the pressure from organized medicine
- 31:04and especially psychiatry, which ~ really did not like that model
- 31:10and exerted a lot of political influence to essentially stop this program.
- 31:17The long-term influence of the program is
- 31:20that this training model that was utilized in the DOD program essentially started
- 31:27to be adopted, one, by APA in terms of its model curriculum
- 31:32and Designation Criteria, and two,
- 31:35form the basis for the MSCP programs that are in existence now.
- 31:40APA started to look at whether or not to become involved in
- 31:44the area of psychopharmacology again
- 31:47kind of in parallel in the late 1980s into the early 1990s.
- 31:53You can see that the first model curriculum actually was developed in 1996.
- 31:58And then the PEP examination, which is still active today,
- 32:04was created in 1999.
- 32:07The Designation Criteria were first created in 2009 and most recently revised
- 32:13in 2019.
- 32:15And now clinical psychopharmacology is officially recognized as
- 32:20one of the psychological specialties.
- 32:23The training outside of the DOD programs started with
- 32:29the certificate programs like the Prescribing Psychologists Register.
- 32:33There were a number of other programs which led
- 32:37to continuing education certificates,
- 32:39but not degrees.
- 32:40And that wasn't initially acceptable in a state like New Mexico that followed
- 32:45initially that model so that you did not need to get an extra master's degree
- 32:52as long as you had the training and the practical experience,
- 32:55you can become a prescriber without that.
- 32:57That has since changed. So New Mexico,
- 32:59just like all the other states now,
- 33:01require the MSCP. So the MSCP program started
- 33:06with the program at ~ the California School of Professional Psychology,
- 33:11which now is at Alliant. We were the first program,
- 33:15established in 1998, and gradually other programs were established.
- 33:20Nova Southeastern ~ is no longer in existence.
- 33:24But the existing programs now are Alliant,
- 33:27NMSU, which was converted from a certificate to a master's program somewhere along
- 33:32the way, ~ Fairleigh Dickinson University,
- 33:36Chicago School, Idaho State, and Drake.
- 33:39Those six programs as of right now are APA-designated.
- 33:44And the seventh program is at the University of Denver,
- 33:47which is not yet APA-designated.
- 33:50~ They will be applying shortly,
- 33:52and most people expect that they will become designated in about a year or so.
- 33:57So the model curriculum essentially,
- 34:00as well as the Designation Criteria,
- 34:02require at least 400 hours, which means that for most universities,
- 34:07that means at least 30 credits of graduate coursework,
- 34:11as well as the practicum and physical health assessment.
- 34:15That practicum is required in the Designation Criteria.
- 34:20And I'll talk about that very shortly.
- 34:23If you want to be eligible then for
- 34:27the recently started board certification in psychopharmacological psychology,
- 34:33then in addition to what's listed above,
- 34:37you must pass the PEP and then complete an additional practicum that
- 34:42is now a psychopharmacology practicum rather than just one ~ focused
- 34:48on physical health assessment.
- 34:50And then of course, if you want to go and prescribe in one of
- 34:53the existing RxP states, you have to review those requirements that
- 34:59are individual for each state,
- 35:00see what else they may require.
- 35:02And generally speaking, they all require the MSCP.
- 35:06What they differ in is what practical experience over and above the MSCP
- 35:12you may be required to complete to be eligible for that license.
- 35:16So how do the training programs differ?
- 35:19There are several dimensions. They differ in terms of how they deliver the classes,
- 35:24whether they're live or online only,
- 35:27whether there are in-person attendance requirements,
- 35:30the actual number of hours and number of credits,
- 35:34how the courses are planned in sequence,
- 35:36what choices you have to complete the practicum,
- 35:41and also how they apply the requirement for the capstone.
- 35:46So let's talk about all these dimensions ~ separately.
- 35:50First thing you should consider when you think about what program is going
- 35:53to be right for you is, is it a live program or is it
- 35:58a fully online asynchronous program?
- 36:01So a live program, a synchronous program,
- 36:04is delivered through live classes,
- 36:07which doesn't mean you have to attend them in person.
- 36:09It means that you have to be present on Zoom when the class is taking place.
- 36:14So those programs tend to try to replicate a live classroom environment,
- 36:20even though you're not attending in person,
- 36:22you're attending it via Zoom. And some programs are 100% live.
- 36:27~ Some programs, like at Alliant,
- 36:30we are a bit of a hybrid.
- 36:32Classes last eight weeks; five of the eight weeks are live,
- 36:36and then there are three weeks that are online only.
- 36:40So various programs, you know,
- 36:42have different ways in which they divide that particular time between live
- 36:47and online. The benefits, ~ you know,
- 36:50obviously is live instruction,
- 36:52ability to ask questions. It's a much more similar experience
- 36:58to a regular classroom.
- 36:59And that's particularly beneficial for students who do better with
- 37:04a structured schedule and deadlines,
- 37:06and for students who don't have a lot of medical background and
- 37:10may find the material challenging or at least at first intimidating.
- 37:16Asynchronous programs are fully online.
- 37:18There's no live classes, they're all done by recordings.
- 37:22There may be a time that's set aside each week for optional meetings with
- 37:27the professor where you can ask some questions,
- 37:29but certainly not a same or similar kind of situation where you would
- 37:35be hearing a lecture. The professor is just there.
- 37:37And if you have some questions or if you want to enter into a discussion,
- 37:41you can do that. The benefit obviously is increased flexibility because
- 37:47you don't have to be present for classes when they're
- 37:50occurring live. And it's good for students who are pretty self-disciplined
- 37:55and will keep up with the schedule of watching the videos and completing what they
- 38:00have to do at their own time, but pace themselves so they can do it,
- 38:04in the length of the course. And maybe particularly well suited for students
- 38:09who are more comfortable with medical material,
- 38:13so they feel better able to comprehend it
- 38:16without necessarily having the professor explain all the different aspects of it.
- 38:21In terms of actual in-person requirements,
- 38:24some programs do not require any in-person attendance for any part of the program,
- 38:30for example, like we do at Alliant.
- 38:32Some programs require at least some courses to be completed,
- 38:36not only live, but actually physically in person.
- 38:39Like when you complete the program at Idaho State,
- 38:42there are some classes you actually physically have to attend in person.
- 38:46Most programs which require practicum for completion mandate that to be in person,
- 38:53but it doesn't have to be in person where the program is located.
- 38:56You can make arrangements locally to complete that practicum.
- 39:01And I'll talk about that in just a couple of minutes.
- 39:04The number of hours and credits does vary to some extent between programs.
- 39:10So the APA Designation Criteria require at least 400 hours of instruction,
- 39:16but it's important to recognize that some of the states actually mandate 450 hours.
- 39:22And to my knowledge, actually all the programs in recognition of that
- 39:26are about 450 hours. You should check with the program.
- 39:32If you want to be licensed in a state that specifically states 450 hours,
- 39:38you should check with the program you may be interested in to see whether
- 39:42or not they actually do provide 450 hours of instruction.
- 39:47In terms of number of credits,
- 39:49~ the baseline number tends to be 30 credits.
- 39:54Like at Alliant, we offer 10 courses,
- 39:57three credits each. So it is ~ 30 credits total,
- 40:02divided equally between the courses.
- 40:05Some programs don't quite divide it that systematically.
- 40:09There may be courses that have more than three credits.
- 40:13There may be courses that have less than three credits.
- 40:16So again,
- 40:17you can look at that and review the curriculum of each program to
- 40:22see exactly how they divide the content into their courses.
- 40:27So the bottom line is the number of actual courses that you need
- 40:32to complete may vary from program to program.
- 40:35I've never seen it to be less than 10,
- 40:38but in some programs it is more than 10.
- 40:41The length of each course also varies.
- 40:43It is common now for programs,
- 40:46if they run on a semester schedule,
- 40:49to offer two courses in one semester,
- 40:53but not running concurrently. So the first half of semester will be one course,
- 40:58the second half will be another course.
- 41:00We do something very similar at Alliant in that we follow the term model,
- 41:05and each term for us is eight weeks.
- 41:09So you complete courses, one course at a time for eight weeks at a time.
- 41:15And then the terms are scattered.
- 41:17For Alliant, you complete three terms in a row if you start in January.
- 41:21Then you have a break over the summer,
- 41:23and then you complete two more terms before the end of the year.
- 41:27Some of the MSCP programs allow students to vary their schedule
- 41:31based on blocks of courses where you have some choice in terms of
- 41:34how you select your courses. That is true of programs,
- 41:38for example, like Chicago School.
- 41:40We follow a different model in that you follow a set sequence of courses
- 41:45at a predetermined scheduled five courses per year.
- 41:49Now, the practicum in physical health assessment is something
- 41:51you really should think about.
- 41:53This practicum is required in the APA Designation Criteria.
- 41:59Some MSCP programs do offer what they call an academic track that does
- 42:05not require the completion of the practicum.
- 42:09You should keep in mind that those academic tracks are not APA-designated.
- 42:14So that may or may not make a difference
- 42:17in what you're doing in the future.
- 42:19You can later complete the practicum in physical health assessment,
- 42:24but it still will not mean that you have completed an APA-designated program,
- 42:29right? So it's a caveat that I think students who are considering that should
- 42:34be aware of.
- 42:36In terms of non-traditional options to complete the practicum,
- 42:39there are two programs that ~ give you an option.
- 42:42What we do at Alliant is we have a virtual practicum option,
- 42:46which means that it is completed live and you're being actually observed live
- 42:53in a one-on-one situation that is,
- 42:55of course, scheduled individually with one of our faculty members.
- 43:00The Chicago School does something a little bit different in that you
- 43:03can complete ~ simulations, which are equivalent of being able
- 43:09to complete the practicum and it meets the APA Designation Criteria standards.
- 43:14So again, if not completed during the MSCP,
- 43:18practicum can later be added. But keep in mind that if you did not
- 43:23in any way complete it,
- 43:24you may not have completed an APA-designated program.
- 43:28Capstone is required of all the programs,
- 43:31and what the APA Designation Criteria mandate is that it needs
- 43:37to be distinct from any evaluation that focuses exclusively
- 43:42on mastery of information. So,
- 43:44in other words, it can't be just a multiple-choice exam that prepares
- 43:49you for the PEP.
- 43:50It must be something in addition to that.
- 43:53And how programs do that varies pretty widely.
- 43:56What we do at Alliant is you do a multiple-choice section,
- 44:01which is like a prep for the PEP,
- 44:04but we also require a written case workup presentation,
- 44:09for which, of course, we give you guidance and a rubric and criteria
- 44:14in terms of what must be included in the case.
- 44:17Most programs do some versions of that.
- 44:21So again, you should look into the program that you're interested in.
- 44:24And that's a question that you should be asking of the program directors.
- 44:28The fellowship in psychopharmacology is something that can be completed after
- 44:33the degree. There's only one program currently,
- 44:36well, actually more than one, because NMSU and now the Colorado program,
- 44:42they have all the requirements that are required for
- 44:47RxP licenses in that state as part of that degree while
- 44:53you are getting the degree. So in those particular programs,
- 44:57for example at NMSU, you cannot get the MSCP if you have not completed both
- 45:03the practicum in physical health assessment
- 45:06as well as the psychopharmacology practicum.
- 45:09Most programs will give you the MSCP after you only do
- 45:13the physical health assessment practicum,
- 45:16and then you can complete the fellowship or the psychopharmacology practicum
- 45:22at a later date, so long as it is pre-approved by the program director,
- 45:27it will count as being part of your MSCP.
- 45:30So, some final thoughts. Psychopharmacology training for psychologists
- 45:33is now well established. It is ~ a well-established specialty with distinctive
- 45:40recognition now of advanced skills.
- 45:43There are three levels of training;
- 45:46Level II and III gives you the most benefits in terms of how it
- 45:50can expand your practice.
- 45:52APA Designation Criteria have standardized most aspects of training,
- 45:56but institutions vary in how they apply and how they meet those criteria.
- 46:02So a good way to look at that is,
- 46:05you know, the model curriculum and the APA Designation Criteria tell
- 46:10you everything that has to be covered.
- 46:12It's almost like they give you the pie itself.
- 46:14Now, how you divide the pie into slices,
- 46:17meaning individual courses,
- 46:19that varies greatly from program to program.
- 46:22It is advisable for potential students to review several programs before making
- 46:26a choice so that you can see exactly what mix of these various aspects
- 46:32of the program ~ works best for you.
- 46:34And price is a consideration because there is a difference in price to some degree.
- 46:39I think all the programs are now within about $5,000
- 46:43overall, for the whole program,
- 46:45of each other. So the price differences are not very significant anymore between
- 46:50the programs. And of course it is a consideration for some students,
- 46:54but you should place it in context of the other variables.
- 46:58Because the bottom line is a program may be cheaper,
- 47:01but if it doesn't work in such a way that you've gained the most out of the program,
- 47:06then you have to think about whether or not that
- 47:08money, in the end, was well-spent.
- 47:10Thoughts, comments? I got a couple of questions,
- 47:13Dr. Kapalka, in the Q&A. The first one,
- 47:16regarding the fellowship experience,
- 47:18does Alliant aid students in seeking specialty population experiences or training?
- 47:24Alliant can help you arrange a placement
- 47:28if you have a population of interest.
- 47:31So what the schools are doing,
- 47:34and you know, keep in mind that,
- 47:37for example, at NMSU, most students in that program are
- 47:43in the process of becoming prescribing psychologists in New Mexico,
- 47:46and the program is specifically geared towards that.
- 47:49At ~ Idaho, the same is true about them.
- 47:53Some other students, of course,
- 47:54complete it too, but the majority of students probably seek licensure in that state.
- 48:00Colorado kind of works the same way.
- 48:02So the programs that primarily aim to train graduates
- 48:08to practice within the state where they're located,
- 48:11chances are, are going to have some sites already
- 48:15developed for students to be able to either come there because they're going
- 48:19to come there anyway, or if they're already there in the first place to
- 48:22be able to do these practicums.
- 48:24Places like Fairleigh Dickinson and Alliant,
- 48:28which we're located in states that don't have RxP,
- 48:31we tend to draw students from across the country.
- 48:35So we do develop some relationship with some sites where you can arrange those kinds
- 48:41of experiences.
- 48:42We do it on a case-by-case basis,
- 48:44depending on how we already have experience with prior students doing
- 48:50it at a particular site, or maybe we have some connections ourselves
- 48:53as program directors or some of our faculty.
- 48:55So it's all arranged on an individual basis.
- 48:59But yes, special population considerations can definitely be included.
- 49:05Can you talk about how training needs may vary depending on setting?
- 49:11For example, inpatient versus outpatient settings.
- 49:14I don't know if any MSCP program would prepare
- 49:20you better for that type of practice than any other,
- 49:23because we all follow a general curriculum model which
- 49:30will definitely include ~ serious mental illness and the kind
- 49:35of medications that may be used in inpatient settings like Clozaril.
- 49:41But of course, we're going to give you experience and exposure
- 49:45to medications more commonly used in outpatient settings,
- 49:49too. So that's something that probably would be more of
- 49:54a specialized placement you could arrange for your practicum
- 49:58in physical assessment as well as for your fellowship,
- 50:02which would then better prepare you for inpatient practice.
- 50:06Where do you see the future of the practice of psychology,
- 50:09given the increased use of medications you mentioned and the decreasing
- 50:14use of psychotherapy?
- 50:15I think psychologists, if they can be at
- 50:20the proverbial table when treatment selection choices are made,
- 50:27they can greatly contribute to the reduction in the utilization of medications.
- 50:33So, in other words, if a primary care practitioner
- 50:38is practicing without a
- 50:42close collaborative relationship with a psychologist,
- 50:46it's more likely that the treatment will be medications only.
- 50:49The way we can really make a difference is to complete
- 50:53the training in psychopharmacology because then we can show physicians that
- 50:58we understand medication treatments.
- 51:01And with that understanding, we're in a better position to redirect
- 51:07some of the treatment that may be done with medications into other treatments
- 51:14like psychotherapy or maybe family approaches.
- 51:17You know, I work a lot with pediatrics,
- 51:19family or working with parents who develop parenting techniques,
- 51:23they're such powerful tools that sometimes can prevent the use of medications,
- 51:29right? But if we approach PCPs or pediatricians,
- 51:35showing them we already have the knowledge of medications,
- 51:38right? They're much more likely to take our input.
- 51:43All right. Next question. Given the increasing emphasis
- 51:46on integrated behavioral health care,
- 51:48do you believe pursuing psychopharmacology education earlier
- 51:53in one's academic career provides an advantage?
- 51:56Or is it more beneficial after completing doctoral training?
- 52:00You know, that's a conversation that's been happening in the MSCP training circles
- 52:06for decades. I do believe there are advantages
- 52:11to starting this early because as you develop your practice
- 52:18as a new psychologist, having an additional skill set with psychopharmacology
- 52:24~ can greatly enhance
- 52:26the direction of how you build your practice in the first place.
- 52:30Having said that, it's certainly not too late.
- 52:32I mean, I was speaking with a psychologist who is in her 70s and she
- 52:37now wants to get her MSCP. She's now slowed down her practice,
- 52:44wants to add another dimension to it,
- 52:45wants to continue to be active,
- 52:48but is looking for a challenge and to kind of take her practice in a new direction.
- 52:53So I'll say two things: ~ Yes,
- 52:57I do believe the earlier the better,
- 52:59but I also will say that I don't think it's ever too late.
- 53:01For someone who already holds a master's degree in psychology with
- 53:06a concentration in forensic psychology,
- 53:09would a graduate certificate in clinical psychopharmacology be beneficial?
- 53:13Or would you recommend waiting until pursuing a doctoral studies?
- 53:17To enter into a Master of Science in Clinical Psychopharmacology,
- 53:23now programs are required to allow you only one of two pathways.
- 53:30You either have to be a licensed psychologist on a doctoral level,
- 53:34or you can be in the doctoral program leading to
- 53:39health service psychology. So,
- 53:41you know, clinical counseling,
- 53:43those will be the primary examples.
- 53:45We can give exceptions for students who've completed their doctorates
- 53:49and maybe are not yet licensed,
- 53:51but it's very clear that they're proceeding towards licensure.
- 53:54Right now, there is no path of entry into MSCP programs for someone
- 53:59who is just master's-trained.
- 54:01Because of how these programs are designed and because of how
- 54:05the APA Designation Criteria work,
- 54:07you would need to wait to be in a doctoral program,
- 54:14then, to potentially be considered for entry into an MSCP.
- 54:18Do you anticipate that psychopharmacology training will eventually become
- 54:23a more standard component of clinical psychology education,
- 54:26even in states that currently do not authorize psychologists to prescribe?
- 54:30If you ask me what the state of the profession will be in fifty years,
- 54:34of course no one has a crystal ball,
- 54:36but my feelings would be that most likely,
- 54:41yes, this will occur in the long term,
- 54:44but I don't think it'll occur in the next 10,
- 54:4715, 20 years.
- 54:49You know, a few things have to happen.
- 54:50So we have to have more states and we have to eventually get to the point where
- 54:54a majority of states have RxP.
- 54:56We're not close to that yet. So that's going to take some time.
- 55:00The second aspect that will have to happen is that,
- 55:04as these various RxP states come online,
- 55:08they all are going to have
- 55:11varying requirements, right? Everybody requires the MSCP,
- 55:15but the practical requirements do vary from state to state.
- 55:18So eventually the field probably will move towards standardizing
- 55:24it so that the practical requirements,
- 55:28the practical experience requirements will be more similar,
- 55:31you know, across all the RxP states.
- 55:35Until those things happen, I think we will continue to be a little
- 55:40bit more fragmented like we are right now.
- 55:42Can you select a specific educational track based on the population you want
- 55:48to work with? Examples: children,
- 55:51adolescent, emerging adults, et cetera.
- 55:53Or do programs cover all populations?
- 55:56Programs cover all populations because they have to.
- 56:00That is what's mandated in the model RxP curriculum as well
- 56:06as in the Designation Criteria.
- 56:08So programs attend to the needs and the treatments of special populations
- 56:15in a variety of ways.
- 56:16At Alliant, we have a separate course devoted to pediatrics
- 56:22and another course devoted to ethnic considerations,
- 56:26pregnancy, and, you know, things like that.
- 56:28We have a section of a course entirely devoted to ~ geriatric care.
- 56:34Right? So programs tend to include that component
- 56:41as part of their curriculum.
- 56:44But all programs have to train for all populations.
- 56:47And where you can really specialize is in your practicums.
- 56:51When you do your practicum in physical health assessment,
- 56:54as well as if you go the next step afterwards,
- 56:58complete that fellowship in psychopharmacology,
- 57:02that's where you can really specialize in a population like pediatrics
- 57:07or another special population.
- 57:08Fantastic.
- 57:10All right, those are all the questions.
- 57:11Thank you all for attending another fabulous presentation with Doctor Kapalka
- 57:16and thank you, Doctor Kapalka,
- 57:17as always. Thank you for joining us and ~ everyone have a great day.